Alterations in serum levels of trace elements in tuberculosis and HIV infections

Kassu, A.; Yabutani, T.; Mahmud, Z. H.; Mohammad, A.; Nguyen, N.; Huong, B. T. M; Hailemariam, G.; Diro, E.; Ayele, B.; Wondmikun, Y.; Motonaka, J.; Ota, F.
May 2006
European Journal of Clinical Nutrition;May2006, Vol. 60 Issue 5, p580
Academic Journal
Objective:To evaluate serum concentrations of trace elements in tuberculosis (TB) patients with or with out human immunodeficiency virus (HIV) coinfection before and after anti-TB chemotherapy.Subjects:A total of 155 TB patients, 74 of which were coinfected with HIV, and 31 healthy controls from Gondar, Ethiopia.Methods:Serum levels of copper, zinc, selenium and iron were determined using an inductively coupled plasma mass spectrometer from all subjects at baseline and from 44 TB patients (22 with HIV coinfection) at the end of an intensive phase of anti-TB chemotherapy.Results:Compared with the control group, the concentrations of iron, zinc and selenium were significantly lower (P<0.05) while that of copper and copper/zinc ratio was significantly higher (P<0.05) in the serum of TB patients. TB patients with HIV coinfection had significantly lower serum zinc and selenium concentrations and significantly higher copper/zinc ratio compared to that in TB patients without HIV coinfection (P<0.05). The serum concentration of zinc had significantly increased at the end of intensive phase of anti-TB chemotherapy in patients without HIV coinfection (P<0.05). An increase in serum selenium level was observed in TB patients with or without HIV coinfection after therapy. On the contrary, serum copper concentration and copper/zinc ratio declined significantly after anti-TB chemotherapy irrespective of HIV serostatus (P<0.05).Conclusions:The results indicate that TB patients have altered profile of trace elements in their sera. This warrants the need for further investigations so that strategies for trace elements supplementation can be planned in addition to their potential as diagnostic parameters in monitoring responses to anti-TB chemotherapy.European Journal of Clinical Nutrition (2006) 60, 580–586. doi:10.1038/sj.ejcn.1602352; published online 7 December 2005


Related Articles

  • Double-dose lopinavir/ritonavir not feasible treatment for children with HIV and TB also receiving rifampicin. Lewis, Jay // Infectious Diseases in Children;Mar2009, Vol. 22 Issue 3, p18 

    The article reports on the findings of a study presented at the 16th Annual Conference on Retrovirus on the treatment of children with HIV and tuberculosis with a double-dose of lopinavir/ritonavir.

  • Rate of Tuberculosis Cases Soars Among People With HIV. Brownworth, Victoria A. // Advocate;9/24/91, Issue 586, p58 

    Focuses on the rise in the rate of tuberculosis cases among people with HIV in the U.S. in 1991. Mode of contracting the disease; Scope of the epidemic in terms of public health concerns; Difficulty of treating the disease in HIV infected persons.

  • Tuberculosis in the 1990s. Barnes, Peter F.; Barrows, Susan A. // Annals of Internal Medicine;9/1/93, Vol. 119 Issue 5, p400 

    Presents a summary of developments in tuberculosis in the U.S. during the 1990s. Discussion on the occurrence of tuberculosis in HIV-infected patients; Information on techniques for diagnosing tuberculosis; Treatment options for tuberculosis.

  • Tuberculosis: an Old but Still Fascinating Disease. Ruef, C. // Infection;Apr2009, Vol. 37 Issue 2, p79 

    The article discusses various reports published within the issue, including one on the topic of latent tuberculosis and its pathogenesis, another one on the study which investigates the sensitivity, specificity and positive and negative predictive values of modern T-cell-based assays, and one on...

  • Drug-Susceptible Tuberculosis Outbreak in a State Correctional Facility Housing HIV-Infected Inmates-South Carolina, 1999-2000.  // MMWR: Morbidity & Mortality Weekly Report;11/24/2000, Vol. 49 Issue 46, p1041 

    Describes the investigation of South Carolina's Department of Corrections and Department of Health and Environmental Control on the outbreak of drug-susceptible tuberculosis (TB). Details on the need for increased vigilance for TB in settings in which HIV-infected persons congregate; Results of...

  • Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy. Naranbhai, Vivek; Hill, Adrian V. S.; Abdool Karim, Salim S.; Naidoo, Kogieleum; Abdool Karim, Quarraisha; Warimwe, George M.; McShane, Helen; Fletcher, Helen // Journal of Infectious Diseases;Feb2014, Vol. 209 Issue 4, p500 

    Background. Eight decades ago, the ratio of monocytes to lymphocytes (hereafter, the “ML ratio”) was noted to affect outcomes of mycobacterial infection in rabbits. Recent transcriptomic studies support a role for relative proportions of myeloid and lymphoid transcripts in...

  • Co-infection with HIV and TB: double trouble. McShane, Helen // International Journal of STD & AIDS;Feb2005, Vol. 16 Issue 2, p95 

    Co-infection with HIV and Mycobacterium tuberculosis is common, particularly in the developing world. Tuberculosis (TB) is the commonest co-infection in HIV-positive individuals, who are at increased risk of both reactivation of latent infection and acquisition of new infection. As the degree of...

  • Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso. Saleri, Nuccia; Dembélé, Sary Mathurin; Villani, Paola; Carvalho, Anna Cristina C.; Cusato, Maria; Bonkoungou, Victor; Nacanabo, Rachel; Kouanda, Seni; Comelli, Mario; Regazzi, Mario; Matteelli, Alberto // Journal of Antimicrobial Chemotherapy (JAC);Feb2012, Vol. 67 Issue 2, p469 

    Objectives Low plasma concentrations of rifampicin, an essential antituberculosis drug, have been reported particularly among HIV co-infected persons. In a prospective, longitudinal study we measured rifampicin systemic exposure at different timepoints during highly active antiretroviral therapy...

  • Once-Daily Quadruple-Drug Therapy with Adefovir Dipivoxil, Lamivudine, Didanosine, and Efavirenz in Treatment-Naive Human Immunodeficiency Virus Type 1--Infected Patients. Skowron, Gail; Kuritzkes, Daniel R.; Thompson, Melanie A.; Squires, Kathleen E.; Goodwin, S. Diane; Dusak, Betsy A.; Tolson, Jerry M.; Stevens, Michael; Yuen, Geoffrey J.; Rooney, James F. // Journal of Infectious Diseases;10/1/2002, Vol. 186 Issue 7, p1028 

    A 48-week open-label study of 11 antiretroviral-naive, human immunodeficiency virus type 1 (HIV-1)-infected adults evaluated once-daily treatment with adefovir dipivoxil, lamivudine, didanosine, and efavirenz. At baseline, the median plasma HIV-1 RNA level was 4.99 log[sub 10] copies/mL, and the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics